Trial · NCT03129100
Adverse events2,782
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,782
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Leukopenia | Blood and lymphatic system disorders | IXE 80Q4W-Lead-in Period | 1 | 348 | 1 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W-Lead-in Period | 0 | 423 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q4W-Group A Extension Period | 0 | 255 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W-Group A Extension Period | 2 | 318 | 2 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q4W-Group B-Randomized Withdrawal Extension Period | 0 | 47 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W-Group B-Randomized Withdrawal Extension Period | 0 | 54 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo-Group B-Randomized Withdrawal Extension Period | 0 | 53 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W/IXE80Q2W-Retreatment Extension Period | 0 | 6 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q4W/IXE80Q4W-Retreatment Extension Period | 1 | 5 | 1 |
| other | Leukopenia | Blood and lymphatic system disorders | PBO/IXE80Q2W-Retreatment Extension Period | 0 | 9 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | PBO/IXE80Q4W-Retreatment Extension Period | 0 | 10 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W-group A Long-term Extension Period | 2 | 306 | 2 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q4W-group A Long-term Extension Period | 0 | 177 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W-Group B-Randomized Withdrawal Long-term Extension Period | 0 | 45 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q4W-Group B-Randomized Withdrawal Long-term Extension Period | 0 | 42 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | PBO-Group B-Randomized Withdrawal Long-term Extension Period | 0 | 30 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q2W/IXE80Q2W-Retreatment Long-term Extension Period | 0 | 6 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | IXE80Q4W/IXE80Q4W-Retreatment Long-term Extension Period | 1 | 4 | 1 |
| other | Leukopenia | Blood and lymphatic system disorders | PBO/IXE80Q2W-Retreatment Long-term Extension Period | 0 | 11 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | PBO/IXE80Q4W-Retreatment Long-term Extension Period | 0 | 15 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03129100/events